ResearcherUniversity of WashingtonActive in the last 2 years

Qingxin Mu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4952-6591; OpenAlex author ID A5004542109. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Chitosan-PEG Nanoparticles for Co-Delivery of Paclitaxel and KRAS G12D-Directed siRNA to Pancreatic Cancer Cells. Last author DOI 10.3390/ijms27167285 ↗
Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for in… Co-author DOI 10.1371/journal.pone.0300723 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu-Ting Chien · 1 shared paper, 2026 · strength 0.36
- Paper Chitosan-PEG Nanoparticles for Co-Delivery of Paclitaxel and KRAS G12D-Directed siRNA to Pancreatic Cancer Cells. DOI 10.3390/ijms27167285 ↗
Rodney J. Y. Ho · 1 shared paper, 2024 · strength 0.28
- Paper Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic … DOI 10.1371/journal.pone.0300723 ↗
James I. Griffin · 1 shared paper, 2024 · strength 0.28
- Paper Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic … DOI 10.1371/journal.pone.0300723 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.